Tekni-Plex Introduces a New Bench-Top Vial Filling and Sealing Machine
The Pentafill L + Fill is a new bench-top vial filling and sealing machine for lab research and small quantity start-up production.
Tekni-Plex launched the Pentafill L + Fill, a new bench-top vial filling and sealing machine for lab research and small quantity start-up production.
With the ability to accommodate five-unit strips of 0.33-mL, 0.6-mL, 1-mL, 3-mL, 5-mL, and 10-ml plastic vials, the machine executes a fill or seal after an operator loads the five-unit strips into a holder, which is then manually inserted into the machine. The vials are then filled and sealed automatically, followed by manual removal of the holder.
The machine comes equipped with a heating head, cold-molding pliers, a sealer, interchangeable holders for different vial capacities, and external controls to perform the fill and seal.
“Up until now, pharmaceutical companies and labs had to manually fill small-scale production vials before inserting them into the machine for sealing. This resulted in fills that were frequently imprecise and therefore not ideal for lab research or therapeutic use. To help eliminate that issue, our customers asked us to create a unit that would provide precision fills, each and every time,” said Melissa Green, global senior director marketing and strategy, Tekni-Plex Healthcare Packaging, in a July 22, 2020 company press release.
“The demand for this type of capability continues to increase as pharmaceutical manufacturers look for alternatives to expensive, hard-to-source glass vials,” Green added, in the press release. “Additionally, new unit dose applications continue to be developed making the Pentafill L + Fill an ideal unit for lab studies and small-scale production.”
Source: Tekni-Plex
Navigating Annex 1 for Early Phase Sterile Fill Finish in Clinical Supplies
November 21st 2024Stay compliant with Annex 1 for early phase sterile fill finish processes. Discover how to implement robust contamination control strategies, integrate isolator technology, and conduct integrity testing to meet stringent European Union standards. The guide provides a comprehensive look at key elements such as PUPSIT, critical zone controls, and monitoring and training for aseptic processes.
Why is the PDA Pharmaceutical Microbiology Conference the Hottest Ticket in the Industry?
October 10th 2024Get a glimpse of the power and popularity behind the PDA Pharmaceutical Microbiology Conference from two planning committee members, Julia Marre, PhD (Associate Director, Scientific and Regulatory Affairs at Pocket Naloxone Corp) and Dawn Watson (Executive Director, Global Micro Quality and Sterility Assurance at Merck). This candid conversation reveals why this industry event is so influential…and always sold out! The speakers discuss what makes the PDA Pharmaceutical Microbiology Conference so vital to industry professionals, as well as how to become a part of this dynamic professional community.
Ensuring Quality from the Start: Raw Materials Testing Support
November 21st 2024Raw Materials are the foundation of every biopharma product. Our ultimate guide highlights how our testing support can help you establish purity, identity, and quality standards, ensuring a smooth manufacturing process and adherence to regulatory requirements.
Ensure the Safety of Allogeneic Therapies with Advanced qPCR Testing
November 21st 2024Elevate your viral screening with Eurofins BioPharma Product Testing’s qPCR- based assays. Our advanced testing goes beyond standard screenings to detect even dormant and hard-to-detect pathogens, ensuring comprehensive safety in every stage of the allogeneic therapy pipeline. Protect your products – and your patients- with industry-leading sensitivity and specificity.
